Transcatheter closure of postsurgical residual ventricular septal defects: Early and mid-term results

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 2, 2010, Pages 246-255

  Dua, Jaspal S ^a   Carminati, Mario ^a   Lucente, Mariella ^a   Piazza, Luciane ^a   Chessa, Massimo ^a   Negura, Diana ^a   Bussadori, Claudio ^a   Saliba, Zakhia ^b   Butera, Gianfranco ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

Amplatzer VCD occluder; Postsurgical residual ventricular septal defects; Transcatheter device closure

Indexed keywords

ANTIBIOTIC AGENT; HEPARIN;

ADULT; AGED; ANEMIA; AORTA INJURY; ARTICLE; ARTIFICIAL EMBOLISM; ATRIOVENTRICULAR BLOCK; BLOOD VESSEL INJURY; BYPASS SURGERY; CARDIAC PATIENT; CARDIOVERSION; CHILD; CLINICAL ARTICLE; DEVICE; ELECTROCARDIOGRAM; FALLOT TETRALOGY; FEMALE; FLUOROSCOPY; FOLLOW UP; HEALTH CENTER; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART SEPTUM DEFECT; HEART TAMPONADE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE VOLUME; HEMATOMA; HEMODYNAMICS; HUMAN; MALE; PERICARDIAL EFFUSION; PNEUMOTHORAX; PRESCHOOL CHILD; REOPERATION; SAFETY; SCHOOL CHILD; SINUS RHYTHM; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REOPERATION; RISK ASSESSMENT; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; YOUNG ADULT;

EID: 76049117236     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22262     Document Type: Article

References (28)

1. Kirklin JW, Barrat-Boyes BG. Ventricular septal defect. In: Kouchoukos NT, Blacksgowe EH, Doty DB, Hawley FL, Karp RB, editors. Cardiac Surgery, 3rd ed. New York: Churchill Livingstone; 1993. pp 850-910.
2. Yaeger SB, Freed MD, Keane JF, et al. Primary surgical closure of ventricular septal defect in the first year of life: Results in 128 infants. J Am Coll Cardiol 1984;3:1269-1276.
3. Bol-Raap G, Weerheim J, Kappetein AP, et al. Follow-up after surgical closure of congenital ventricular septal defects. Eur J Cardiothorac Surg 2003;24:511-515.
4. Mavroudis C, Backer CL, Jacobs JP. Ventricular septal defect. In: Pediatric Cardiac Surgery, 3rd ed, Philadelphia, PA: Mosby; 2003. pp 298-320.
5. Walsh MA, Coleman DM, Oslizlok P, et al. Percutaneous closure of postoperative ventricular septal defects with the Amplatzer device. Catheter Cardiovasc Interv 2006;67:445-451.
6. Chessa M, Carminati M, Cao QL. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 2002;14:322-327.
7. Hijazi ZM. Device closure of ventricular septal defects. Cathet Cardiovasc Intervent 2003;60:107-114.
8. Bass JL, Kalra GS, Arora R, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Cathet Cardiovasc Intervent 2003;58:238-245.
9. Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Cathet Cardiovasc Interv 2002;56:508-515.
10. Chessa M, Butera G, Negura D, et al. Transcatheter closure of congenital ventricular septal defects in adult: Mid-term results and complications. Int J Cardiol 2009;20:70-73.
11. Carminati M, Butera G, Chessa M, et al. (For the Investigators of the European VSD Registry). Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007 Oct;28:2361-2368.
12. Kidd L, Driscoll DJ, Gersony WM, et al. Second natural history study of congenital heart defects: Results of treatment of patients with ventricular septal defects. Circulation 1993; 87:(Suppl I)138-151.
13. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Outcome of patients after surgical closure of ventricular septal defect at young age: Longitudinal follow-up of 22-34 years. Eur Heart J 2004;24:1057-1062.
14. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-1065.
15. Zhong-Dong Du, Hijazi ZM, Kleinman CS, et al. Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults. J Am Coll Cardiol 2002;39:1836-1844.
16. Butera G, Carminati M, Chessa M, et al. Percutaneous versus surgical closure of secundum atrial septal defect: Comparison of early results and complications. Am Heart J 2006;151:228-234.
17. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the Amplatzer PDA device: Immediate results of the international clinical trial. Cathet Cardiovasc Intervent 2000;51:50-54.
18. Pass RH, Hijazi Z, Hsu DT, et al. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial. J Am Coll Cardiol 2004;44:513-519.
19. Knauth AL, Lock JE, Perry SB, et al. Transcatheter device closure of congenital and post-operative residual ventricular septal defect. Circulation 2004;110:501-507.
20. Arora R, Trehan V, Kumar A, et al. Transcatheter closure of congenital ventricular septal defects. Experience with various devices. J Interv Cardiol 2003;16:83-91.
21. Thanopoulos BV, Rigby ML, Karanasios E, et al. Transcatheter closure of perimembranous ventricular septal defects in infants and children using the amplatzer perimembranous ventricular septal defect occluder. Am J Cardiol 2007;99:984-989.
22. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol 2005;96:52L-58L.
23. Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects early and longterm results. J Am Coll Cardiol 2007;50:1189-1195.
24. Holzer R, Balzer D, Cao QL, et al. Amplatzer muscular ventricular septal defect investigators. Device closure of muscular ventricular septal defects using the amplatzer muscular ventricular septal defect occluder immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004;43:1257-1263.
25. Pedra CA, Pontes SC, Pedra SR, et al. Percutaneous closure of postoperative and post-traumatic ventricular septal defects. J Invasive Cardiol 2007;19:491-495.
26. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of periemembranous ventricular septal defects using the new Amplatzer membranous VSD occluder. Results of the US phase I trial. J Am Coll Cardiol 2006;47:319-325.
27. Pinto RJ, Dalvi BV, Sharma S. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer asymmetric ventricular septal defect occluder: Preliminary experience with 18-month follow-up. Catheter Cardiovasc Interv 2006;68:145-152.
28. Perry YY, Triedman JK, Gauvreau K, et al. Sudden death in patients after transcatheter device implantation for congenital heart disease. Am J Cardiol 2000;85:992-995.